Guner, R., Hasanoglu, I., Kayaaslan, B., Aypak, A., Akinci, E., Bodur, H., Eser, F., Kaya Kalem, A., Kucuksahin, O., Ates, I., Bastug, A., Tezer Tekce, Y., Bilgic, Z., Gursoy, F. M., Akca, H. N., Izdes, S., Erdem, D., Asfuroglu, E., Hezer, H., Kilic, H., Cıvak, M., Aydogan, S., & Buzgan, T. (2021). comparing ICU admission rates of mild/moderate COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir. Journal of infection and public health, 14(3), 365–370. http://access.bl.uk/ark:/81055/vdc_100124049220.0x000013